Cystoscopy, an indispensable tool for the diagnosis and prognosis of bladder pain syndrome, takes nomograms for predicting recurrence.


Journal

World journal of urology
ISSN: 1433-8726
Titre abrégé: World J Urol
Pays: Germany
ID NLM: 8307716

Informations de publication

Date de publication:
Sep 2023
Historique:
received: 20 05 2023
accepted: 30 06 2023
medline: 31 8 2023
pubmed: 16 7 2023
entrez: 15 7 2023
Statut: ppublish

Résumé

We aimed to illustrate the importance of cystoscopy for the diagnosis and prognosis of bladder pain syndrome (BPS) or interstitial cystitis (IC). We designed a 4-year prospective follow-up study. Patients who underwent cystoscopy between May 2011 and July 2021 with a diagnosis of BPS/IC before surgery or positive cystoscopic findings during initial surgery at Peking University People's Hospital were enrolled. Data related to symptom recurrence were obtained through clinic visits and telephone follow-up. We compared the differences in clinical features of BPS/IC subtypes differentiated by cystoscopy and first created clinical predictive nomograms for BPS/IC. A total of 141 patients were included. There was an 8.51% chance of BPS/IC being misdiagnosed as other diseases or other diseases being misdiagnosed as BPS/IC without cystoscopy. Patients with HIC had higher pain scores and ICPI, higher residual urine volume, lower first-sense-to-void, and maximum cystometric bladder capacities than NHIC. Nomogram Models showed that patients who with higher ICPI, ICSI and lower AMBC have a greater recurrence probability, and lesions in the trigone may indicate a greater likelihood of recurrence than lesions in other bladder walls. Timely detection of bladder cancer and other diseases using cystoscopy can avoid poor treatment effects. BPS/IC subtypes can be classified according to mucosal changes under cystoscopy. Lesions in the bladder triangle can indicate a higher recurrence risk, which is important in follow-up treatment. We strongly recommend that cystoscopy should be included in the international BPS/IC diagnostic criteria.

Identifiants

pubmed: 37453960
doi: 10.1007/s00345-023-04517-6
pii: 10.1007/s00345-023-04517-6
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2451-2458

Subventions

Organisme : Natural Science Research of Jiangsu Higher Education Institutions of China
ID : 81970660

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Homma Y, Akiyama Y, Tomoe H et al (2020) Clinical guidelines for interstitial cystitis/bladder pain syndrome. Int J Urol 27:578–589. https://doi.org/10.1111/iju.14234
doi: 10.1111/iju.14234 pubmed: 32291805
Wein AJ, Hanno PM, Gillenwater JY (1990) Interstitial cystitis: an introduction to the problem. In: Hanno PM, Staskin DR, Krane RJ, Wein AJ (eds) Interstitial Cystitis. Springer, London, pp 3–15
doi: 10.1007/978-1-4471-3293-6_1
Hanno PM, Landis JR et al (1999) The diagnosis of interstitial cystitis revisited: lessons learned from the national institutes of health interstitial cystitis database study. J Urol 161:553–557. https://doi.org/10.1016/S0022-5347(01)61948-7
doi: 10.1016/S0022-5347(01)61948-7 pubmed: 9915447
van de Merwe JP, Nordling J, Bouchelouche P et al (2008) Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal. Eur Urol 53:60–67. https://doi.org/10.1016/j.eururo.2007.09.019
doi: 10.1016/j.eururo.2007.09.019 pubmed: 17900797
Hanno P, Lin A, Nordling J et al (2010) Bladder pain syndrome international consultation on incontinence. Neurourol Urodyn 29:191–198. https://doi.org/10.1002/nau.20847
doi: 10.1002/nau.20847 pubmed: 20025029
Hanno PM, Burks DA, Clemens JQ et al (2011) AUA Guideline for the diagnosis and treatment of interstitial cystitis/bladder pain syndrome. J Urol 185:2162–2170. https://doi.org/10.1016/j.juro.2011.03.064
doi: 10.1016/j.juro.2011.03.064 pubmed: 21497847 pmcid: 9341322
Wein AJ (2004) Primary evaluation of patients suspected of having Interstitial Cystitis (IC). J Urol 172:2494–2495. https://doi.org/10.1016/S0022-5347(05)61463-2
doi: 10.1016/S0022-5347(05)61463-2
Ahn ST, Jeong HG, Park TY et al (2022) Cancer statistics, 2022. CA A Cancer J Clin 72:7–33. https://doi.org/10.3322/caac.21708
doi: 10.3322/caac.21708
Fall M, Johansson SL, Aldenborg F (1987) chronic interstitial cystitis: a heterogeneous syndrome. J Urol 137:35–38. https://doi.org/10.1016/S0022-5347(17)43863-8
doi: 10.1016/S0022-5347(17)43863-8 pubmed: 3795363
Nickel JC, Doiron RC (2020) Hunner lesion interstitial cystitis: the bad, the good, and the unknown. Eur Urol 78:e122–e124. https://doi.org/10.1016/j.eururo.2020.04.067
doi: 10.1016/j.eururo.2020.04.067 pubmed: 32507337
Han J, Shin JH, Choo M (2019) Patterns and predictors of Hunner lesion recurrence in patients with interstitial cystitis. Neurourol Urodyn 38:1392–1398. https://doi.org/10.1002/nau.23998
doi: 10.1002/nau.23998 pubmed: 30945347
Ronstrom C, Lai HH (2020) Presenting an atlas of Hunner lesions in interstitial cystitis which can be identified with office cystoscopy. Neurourol Urodyn 39:2394–2400. https://doi.org/10.1002/nau.24500
doi: 10.1002/nau.24500 pubmed: 32902893
Doiron RC, Tolls V, Irvine-Bird K et al (2016) Clinical phenotyping does not differentiate hunner lesion subtype of interstitial cystitis/bladder pain syndrome: a relook at the role of cystoscopy. J Urol 196:1136–1140. https://doi.org/10.1016/j.juro.2016.04.067
doi: 10.1016/j.juro.2016.04.067 pubmed: 27117441
Ahn ST, Jeong HG, Park TY et al (2018) Differences in urodynamic parameters according to the presence of a hunner lesion in women with interstitial cystitis/bladder pain syndrome. CA A Cancer J Clin 22:S55-61. https://doi.org/10.5213/inj.1835044.522
doi: 10.5213/inj.1835044.522
Peeker R (2002) Toward a precise definition of interstitial cystitis: further evidence of differences in classic and nonulcer disease. J Urol 167:2470–2472. https://doi.org/10.1016/S0022-5347(05)65006-9
doi: 10.1016/S0022-5347(05)65006-9 pubmed: 11992059

Auteurs

Lin Zhu (L)

Department of Urology, Peking University People's Hospital, Beijing, 100044, China.
Peking University Applied Lithotripsy Institute, Peking University People's Hospital, Beijing, 10034, China.

Hanwei Ke (H)

Department of Urology, Peking University People's Hospital, Beijing, 100044, China.
Peking University Applied Lithotripsy Institute, Peking University People's Hospital, Beijing, 10034, China.

Qi Wang (Q)

Department of Urology, Peking University People's Hospital, Beijing, 100044, China.
Peking University Applied Lithotripsy Institute, Peking University People's Hospital, Beijing, 10034, China.

Kexin Xu (K)

Department of Urology, Peking University People's Hospital, Beijing, 100044, China. cavinx@yeah.net.
Peking University Applied Lithotripsy Institute, Peking University People's Hospital, Beijing, 10034, China. cavinx@yeah.net.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH